News
The first blood test to help diagnose Alzheimer’s disease will be available from late June in the US following regulatory ...
Fujirebio today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the company’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results